- Home
- NAMS vs NBTB Comparison
NAMS vs NBTB Comparison
Compare NAMS & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- NBTB
- Stock Information
- Founded
- NAMS 2019
- NBTB 1856
- Country
- NAMS Netherlands
- NBTB United States
- Employees
- NAMS N/A
- NBTB N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- NBTB Major Banks
- Sector
- NAMS Health Care
- NBTB Finance
- Exchange
- NAMS Nasdaq
- NBTB Nasdaq
- Market Cap
- NAMS 2.2B
- NBTB 2.0B
- IPO Year
- NAMS N/A
- NBTB N/A
- Fundamental
- Price
- NAMS $18.11
- NBTB $41.85
- Analyst Decision
- NAMS Strong Buy
- NBTB Buy
- Analyst Count
- NAMS 6
- NBTB 3
- Target Price
- NAMS $42.83
- NBTB $52.33
- AVG Volume (30 Days)
- NAMS 694.5K
- NBTB 321.4K
- Earning Date
- NAMS 05-08-2025
- NBTB 07-21-2025
- Dividend Yield
- NAMS N/A
- NBTB 3.25%
- EPS Growth
- NAMS N/A
- NBTB 17.05
- EPS
- NAMS N/A
- NBTB 3.03
- Revenue
- NAMS $47,140,000.00
- NBTB $569,473,000.00
- Revenue This Year
- NAMS N/A
- NBTB $26.51
- Revenue Next Year
- NAMS N/A
- NBTB $12.04
- P/E Ratio
- NAMS N/A
- NBTB $13.81
- Revenue Growth
- NAMS 586.97
- NBTB 13.26
- 52 Week Low
- NAMS $14.06
- NBTB $34.47
- 52 Week High
- NAMS $27.29
- NBTB $52.44
- Technical
- Relative Strength Index (RSI)
- NAMS 47.80
- NBTB 43.88
- Support Level
- NAMS $16.79
- NBTB $40.91
- Resistance Level
- NAMS $19.58
- NBTB $42.74
- Average True Range (ATR)
- NAMS 0.94
- NBTB 0.87
- MACD
- NAMS -0.12
- NBTB -0.25
- Stochastic Oscillator
- NAMS 47.07
- NBTB 20.22
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.